Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent and VitaFlow valve

Sponsored by MicroPort
Other coronary interventions
Stents and scaffolds
Coronary Interventions
Interventions for Valvular Disease

Join us if you want

  • To learn the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools
  • To learn the features and benefits of PCI robot R-ONE and first clinical trial updates in China
  • To learn the five-year clinical results of VitaFlow Transcatheter Aortic Valve System

Anchorperson: Andreas Baumbach

Moderator: Pieter Smits

Discussant: Bo Xu

Chatmaster: Wei Liu

Speakers: Yundai Chen, Mao Chen, Ling Tao

Session objectives

Andreas Baumbach

PCI Robot R-ONE: progress from the China pivotal study

Yundai Chen

Discussion and audience interaction
Firehawk stent in STEMI: primary endpoint results from TARGET STEMI OCT China trial

Ling Tao

Discussion and audience interaction
VitaFlow in severe aortic stenosis patient: five-year clinical outcomes

Mao Chen

Discussion and audience interaction
Session evaluation and key learnings

Pieter Smits